About Us
Medical Blog
  • Medtronic Acquires Aptus Endosystems for $110 Million

    Medtronic PLC recently announced its acquisition of Aptus Endosystems, further adding to its portfolio of medical device products. The acquisition was reported to be valued at approximately $110 million. According to its website, Aptus Endosystems produces advanced technology for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR).  Its products are said to s ...
  • House Committee Passes Innovation Act – Medical Device Group Expresses Opposition

    The Innovation Act (H.R. 9), a patent reform bill introduced this congressional session, received bipartisan support in a 24-8 positive vote by the House Judiciary Committee on June 11, 2015. The bill is now scheduled to proceed to the full House of Representatives for consideration. A press release announcing the vote stated that a goal of the Innovation Act is to address, for example, the follo ...
  • IEEE Releases Med Device Cybersecurity Guidelines

    Amid myriad media reports about potential vulnerabilities in medical device cybersecurity and the FDA's efforts to strengthen medical device cybersecurity, the IEEE Cybersecurity Initiative released a report entitled "Building Code for Medical Device Software Security." The report sets forth a set of elements aimed at reducing the vulnerability of medical device software to malicious attack ...
  • Sep


    SYNAPSE 2015

    Center for Entrepreneurial Innovation (CEI)

    September 17 - 19, 2015

    Phoenix, AZ

    A workshop event taking medtech ideas from mind to matter. Synapse is more than just an event, it is a combination of education and resource sponsors designed to light a fire under new medical technologies. In addition to a wealth of education, participants have the opportunity to reach prototype, patent pending application and vetted business […]

  • Oct


    TCT 2015 – Transcatheter Cardiovascular Therapeutics

    October 12 - 16, 2015

    San Francisco, CA

    Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content. TCT showcases the latest advances in current therapies and clinical research. Our longstanding commitment to lifesaving innovation translates into improved patient care.

  • Nov


    Vascular InterVentional Advances (VIVA)

    Wynn Hotel

    November 02 - 5, 2015

    Las Vegas, NV

    VIVA is the premier global, multidisciplinary course for vascular intervention and medicine. For the past 11 years, VIVA has defined excellence in professional education by offering attendees an innovative, provocative, and balanced educational experience, enhanced by the use of technology and electronic interaction between participants and faculty experts.